Thursday | Dec 05 2024 |
Gland Pharma has announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Latanoprost Ophthalmic Solution, 0.005 per cent (2.5 mL fill)
Subscribe to our newsletter to get updates on our latest news
